# Plerixafor

NDC: 68083-155
Generic name: Plerixafor
Labeler / Manufacturer: Gland Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20240503

FDA application: ANDA206644

## Active ingredients

- PLERIXAFOR: 24 mg/1.2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68083-155"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68083-155
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fad65f5b-be13-4d3a-8df3-dace8e02708f